2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine
C125H125F3N48O8 — CID 157060505
Data last refreshed: (MolForge compound catalog, from PubChem)
IUPAC2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine
SMILESCC(C)(O)Cn1cc(-c2nc(C3(c4ccc(-c5ccc(N)nc5)nc4)CCC3)no2)cn1.CC(C)n1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)nc4)CCC3)no2)cn1.CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)cn5)nc4)CCC3)no2)cn1.CNc1cnc(-c2ccc(C3(c4noc(-c5cnn(C)c5)n4)CCC3)cn2)cn1.Nc1ncc(-c2ccc(C3(c4noc(-c5cnn(C(F)F)c5)n4)CCC3)cn2)cn1.Nc1ncc(-c2ccc(C3(c4noc(-c5cnn(CCF)c5)n4)CCC3)cn2)cn1
InChIInChI=1S/C23H25N7O2.C22H23N9O2.C21H22N8O.C20H19FN8O.C20H20N8O.C19H16F2N8O/c1-22(2,31)14-30-13-16(11-27-30)20-28-21(29-32-20)23(8-3-9-23)17-5-6-18(25-12-17)15-4-7-19(24)26-10-15;1-30(2)19(32)13-31-12-14(8-27-31)20-28-21(29-33-20)22(6-3-7-22)15-4-5-16(24-9-15)17-10-26-18(23)11-25-17;1-13(2)29-12-15(10-26-29)18-27-19(28-30-18)21(6-3-7-21)16-4-5-17(23-11-16)14-8-24-20(22)25-9-14;21-6-7-29-12-14(10-26-29)17-27-18(28-30-17)20(4-1-5-20)15-2-3-16(23-11-15)13-8-24-19(22)25-9-13;1-21-17-11-23-16(10-24-17)15-5-4-14(9-22-15)20(6-3-7-20)19-26-18(29-27-19)13-8-25-28(2)12-13;20-17(21)29-10-12(8-26-29)15-27-16(28-30-15)19(4-1-5-19)13-2-3-14(23-9-13)11-6-24-18(22)25-7-11/h4-7,10-13,31H,3,8-9,14H2,1-2H3,(H2,24,26);4-5,8-12H,3,6-7,13H2,1-2H3,(H2,23,26);4-5,8-13H,3,6-7H2,1-2H3,(H2,22,24,25);2-3,8-12H,1,4-7H2,(H2,22,24,25);4-5,8-12H,3,6-7H2,1-2H3,(H,21,24);2-3,6-10,17H,1,4-5H2,(H2,22,24,25)
InChIKeyABGWHYZGGINHNW-UHFFFAOYSA-N
MW2484.70 g/mol
LogP17.43
Rot. Bonds33
About 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine
2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine (PubChem CID 157060505) has the molecular formula C125H125F3N48O8 and a molecular weight of 2484.70 g/mol. Its IUPAC name is 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine.
Molecular Properties
| Compound Name | 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine |
|---|---|
| PubChem CID | 157060505 |
| Molecular Formula | C125H125F3N48O8 |
| Molecular Weight | 2484.70 g/mol |
| Exact Mass | 2483.08 |
| IUPAC Name | 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine |
| SMILES | CC(C)(O)Cn1cc(-c2nc(C3(c4ccc(-c5ccc(N)nc5)nc4)CCC3)no2)cn1.CC(C)n1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)nc4)CCC3)no2)cn1.CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)cn5)nc4)CCC3)no2)cn1.CNc1cnc(-c2ccc(C3(c4noc(-c5cnn(C)c5)n4)CCC3)cn2)cn1.Nc1ncc(-c2ccc(C3(c4noc(-c5cnn(C(F)F)c5)n4)CCC3)cn2)cn1.Nc1ncc(-c2ccc(C3(c4noc(-c5cnn(CCF)c5)n4)CCC3)cn2)cn1 |
| InChI | InChI=1S/C23H25N7O2.C22H23N9O2.C21H22N8O.C20H19FN8O.C20H20N8O.C19H16F2N8O/c1-22(2,31)14-30-13-16(11-27-30)20-28-21(29-32-20)23(8-3-9-23)17-5-6-18(25-12-17)15-4-7-19(24)26-10-15;1-30(2)19(32)13-31-12-14(8-27-31)20-28-21(29-33-20)22(6-3-7-22)15-4-5-16(24-9-15)17-10-26-18(23)11-25-17;1-13(2)29-12-15(10-26-29)18-27-19(28-30-18)21(6-3-7-21)16-4-5-17(23-11-16)14-8-24-20(22)25-9-14;21-6-7-29-12-14(10-26-29)17-27-18(28-30-17)20(4-1-5-20)15-2-3-16(23-11-15)13-8-24-19(22)25-9-13;1-21-17-11-23-16(10-24-17)15-5-4-14(9-22-15)20(6-3-7-20)19-26-18(29-27-19)13-8-25-28(2)12-13;20-17(21)29-10-12(8-26-29)15-27-16(28-30-15)19(4-1-5-19)13-2-3-14(23-9-13)11-6-24-18(22)25-7-11/h4-7,10-13,31H,3,8-9,14H2,1-2H3,(H2,24,26);4-5,8-12H,3,6-7,13H2,1-2H3,(H2,23,26);4-5,8-13H,3,6-7H2,1-2H3,(H2,22,24,25);2-3,8-12H,1,4-7H2,(H2,22,24,25);4-5,8-12H,3,6-7H2,1-2H3,(H,21,24);2-3,6-10,17H,1,4-5H2,(H2,22,24,25) |
| InChIKey | ABGWHYZGGINHNW-UHFFFAOYSA-N |
| XLogP | 17.43 |
| TPSA | 742.24 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 55 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 184 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2484.70 |
| LogP ≤ 5 | 17.43 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 55 |
Frequently Asked Questions
What is the IUPAC name of 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine?
The IUPAC name of 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine (CID 157060505) is 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine.
What is the SMILES notation for 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine?
The canonical SMILES for 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine is CC(C)(O)Cn1cc(-c2nc(C3(c4ccc(-c5ccc(N)nc5)nc4)CCC3)no2)cn1.CC(C)n1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)nc4)CCC3)no2)cn1.CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)cn5)nc4)CCC3)no2)cn1.CNc1cnc(-c2ccc(C3(c4noc(-c5cnn(C)c5)n4)CCC3)cn2)cn1.Nc1ncc(-c2ccc(C3(c4noc(-c5cnn(C(F)F)c5)n4)CCC3)cn2)cn1.Nc1ncc(-c2ccc(C3(c4noc(-c5cnn(CCF)c5)n4)CCC3)cn2)cn1.
What is the InChIKey of 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine?
The InChIKey is ABGWHYZGGINHNW-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H25N7O2.C22H23N9O2.C21H22N8O.C20H19FN8O.C20H20N8O.C19H16F2N8O/c1-22(2,31)14-30-13-16(11-27-30)20-28-21(29-32-20)23(8-3-9-23)17-5-6-18(25-12-17)15-4-7-19(24)26-10-15;1-30(2)19(32)13-31-12-14(8-27-31)20-28-21(29-33-20)22(6-3-7-22)15-4-5-16(24-9-15)17-10-26-18(23)11-25-17;1-13(2)29-12-15(10-26-29)18-27-19(28-30-18)21(6-3-7-21)16-4-5-17(23-11-16)14-8-24-20(22)25-9-14;21-6-7-29-12-14(10-26-29)17-27-18(28-30-17)20(4-1-5-20)15-2-3-16(23-11-15)13-8-24-19(22)25-9-13;1-21-17-11-23-16(10-24-17)15-5-4-14(9-22-15)20(6-3-7-20)19-26-18(29-27-19)13-8-25-28(2)12-13;20-17(21)29-10-12(8-26-29)15-27-16(28-30-15)19(4-1-5-19)13-2-3-14(23-9-13)11-6-24-18(22)25-7-11/h4-7,10-13,31H,3,8-9,14H2,1-2H3,(H2,24,26);4-5,8-12H,3,6-7,13H2,1-2H3,(H2,23,26);4-5,8-13H,3,6-7H2,1-2H3,(H2,22,24,25);2-3,8-12H,1,4-7H2,(H2,22,24,25);4-5,8-12H,3,6-7H2,1-2H3,(H,21,24);2-3,6-10,17H,1,4-5H2,(H2,22,24,25).
What are the key properties of 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine?
2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine has a molecular weight of 2484.70 g/mol, XLogP of 17.43, 33 rotatable bonds, 7 hydrogen bond donors, and 55 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[3-[1-[6-(5-aminopyrazin-2-yl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;1-[4-[3-[1-[6-(6-amino-3-pyridinyl)-3-pyridinyl]cyclobutyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-2-methylpropan-2-ol;5-[5-[1-[5-[1-(difluoromethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[1-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine;N-methyl-5-[5-[1-[5-(1-methylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrazin-2-amine;5-[5-[1-[5-(1-propan-2-ylpyrazol-4-yl)-1,2,4-oxadiazol-3-yl]cyclobutyl]-2-pyridinyl]pyrimidin-2-amine is sourced from PubChem (CID 157060505), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157060505 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.